-+ 0.00%
-+ 0.00%
-+ 0.00%

Citigroup Maintains Neutral on Integra Lifesciences, Raises Price Target to $19

Benzinga·07/08/2026 15:39:45
Listen to the news
Citigroup analyst Joanne Wuensch maintains Integra Lifesciences (NASDAQ:IART) with a Neutral and raises the price target from $16 to $19.